首页|丙戊酸脑病临床诊疗的新进展

丙戊酸脑病临床诊疗的新进展

Research progress of diagnosis and treatment for valproic acid encephalopathy

扫码查看
丙戊酸(VPA)是常用处方药,用于治疗复杂的部分性癫痫发作、失神发作、双相情感障碍和预防偏头痛.VPA通常耐受性良好,不良反应轻,但VPA脑病却是一种少见又严重但可逆的不良反应,患者会出现昏迷、脑水肿和死亡.VPA脑病在临床中很容易被忽视,导致延迟诊断和治疗,危及生命.早期识别和治疗VPA脑病至关重要.本文对与VPA脑病相关的流行病学、临床特征、发病机制、危险因素、诊断和治疗等进行综述,为临床提供参考.
Valproic acid(VPA)is a commonly used prescription drug.It is used in various dosage forms to treat complex partial seizures,absence seizures,bipolar affective disorder,and migraine prevention.VPA is generally well tolerated with mild adverse reactions,while VPA encephalopathy,that a few patients will suffer from coma,brain edema,and death,is a rare but severe complication of VPA,which is easily ignored in clinical practice,leading to delayed diagnosis and treatment and life-threatening.VPA encephalopathy is reversible if it can be identified and treated early.Early recognition and treatment of VPA encephalopathy is critical.This article reviews the epidemiology,clinical characteristics,pathogenesis,risk factors,diagnosis,and treatment related to VPA encephalopathy,providing reference for clinical practice.

valproic acidencephalopathydiagnosispathogenesisclinical featuresresearch progress

田野、袁恒杰

展开 >

天津医科大学总医院,天津 300052

天津市神经病学研究所,天津 300052

丙戊酸 脑病 诊断 发病机制 临床特征 研究进展

2024

天津药学
天津市医药集团有限公司 天津市药学会

天津药学

影响因子:0.794
ISSN:1006-5687
年,卷(期):2024.36(1)
  • 35